Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Elborn

Showing results (221-230 of 270) with videos related to

Pageof 27
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 7, 2021
Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftorGisli G Einarsson, Nicola J Ronan, Denver Mooney, et al.
Annals of the American Thoracic Society|December 22, 2022
Clinimetric Properties of Outcome Measures in BronchiectasisJudy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 20, 2021
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosisJ Stuart Elborn, Michael W Konstan, Jennifer L Taylor-Cousar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 19, 2011
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosisCharles S Haworth, Linda Sharples, Vikki Hughes, et al.
American Journal of Respiratory Cell and Molecular Biology|April 29, 2022
Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease PersistenceBethany D Batson, Bryan T Zorn, Giorgia Radicioni, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 4, 2020
Finding the relevance of antimicrobial stewardship for cystic fibrosisJonathan D Cogen, Barbara C Kahl, Holly Maples, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2013
An official American Thoracic Society research statement: comparative effectiveness research in pulmonary, critical care, and sleep medicineShannon S Carson, Christopher H Goss, Sanjay R Patel, et al.
Chest|October 18, 2017
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With IvacaftorNicola J Ronan, Gisli G Einarsson, Maria Twomey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 29, 2023
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatmentGisli G Einarsson, Laura J Sherrard, Joseph E Hatch, et al.
Pageof 27

Showing results (221-230 of 270) with videos related to

Sort By:
Pageof 27
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 7, 2021
Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftorGisli G Einarsson, Nicola J Ronan, Denver Mooney, et al.
Annals of the American Thoracic Society|December 22, 2022
Clinimetric Properties of Outcome Measures in BronchiectasisJudy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 20, 2021
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosisJ Stuart Elborn, Michael W Konstan, Jennifer L Taylor-Cousar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 19, 2011
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosisCharles S Haworth, Linda Sharples, Vikki Hughes, et al.
American Journal of Respiratory Cell and Molecular Biology|April 29, 2022
Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease PersistenceBethany D Batson, Bryan T Zorn, Giorgia Radicioni, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 4, 2020
Finding the relevance of antimicrobial stewardship for cystic fibrosisJonathan D Cogen, Barbara C Kahl, Holly Maples, et al.
American Journal of Respiratory and Critical Care Medicine|October 29, 2013
An official American Thoracic Society research statement: comparative effectiveness research in pulmonary, critical care, and sleep medicineShannon S Carson, Christopher H Goss, Sanjay R Patel, et al.
Chest|October 18, 2017
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With IvacaftorNicola J Ronan, Gisli G Einarsson, Maria Twomey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 29, 2023
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatmentGisli G Einarsson, Laura J Sherrard, Joseph E Hatch, et al.
Pageof 27